Business · 01/09/2011Updated: 10/17/2026 · 1 min read
FDA Releases Guidance on PET Drug Applications for New Drug Submissions
Summary
The Food and Drug Administration (FDA) has made available a new guidance document to help manufacturers of positron emission tomography (PET) drugs prepare and submit new drug applications (NDAs) or abbreviated new drug applications (ANDAs) in compliance with federal regulations.
Original source language: Federal Register — Health and Human ServicesOpen original release →